Attention Investors : Prevent Unauthorized Transactions in your Trading / demat account --> Update your Mobile Number & e mail id with your Broker / Depository Participant. Receive alerts on your Registered Mobile for all Transactions / debit and other important transactions in your Trading / demat account directly from Exchanges & CDSL on the same day..........Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
SCORES - Filing compliant on SCORES – Easy & quick    a. Register on SCORES portal.    b. Mandatory details for filing complaints on SCORES : Name, PAN, Address, Mobile Number, Email ID.    c. Benefits : Effective communication . Speedy redressal of the grievances Website : https://scores.gov.in
Equities | Mutual Funds | Commodities | Derivatives | IPO | Insurance
Thursday, May 2, 2024  15 mins delay  Sensex :  74,611.11Asian Paints: 2,973.80  [96.75]Axis Bank: 1,149.75  [16.40]Bajaj Finance: 6,881.00  [50.05]Bajaj Finserv: 1,616.00  [0.30]Bharti Airtel: 1,306.15  [16.70]HCL Technologies: 1,360.40  [7.15]HDFC Bank: 1,533.00  [15.95]Hind. Unilever: 2,225.45  [5.25]ICICI Bank: 1,139.90  [12.15]IndusInd Bank: 1,505.70  [9.90]Infosys: 1,414.85  [6.25]ITC: 439.10  [3.50]JSW Steel: 890.60  [8.00]Kotak Mah. Bank: 1,575.80  [47.95]Larsen & Toubro: 3,597.60  [3.45]M & M: 2,184.45  [28.15]Maruti Suzuki: 12,793.75  [12.70]Nestle India: 2,511.30  [5.25]NTPC: 369.35  [6.25]Power Grid Corpn: 313.45  [11.80]Reliance Industr: 2,932.10  [0.95]St Bk of India: 830.05  [4.35]Sun Pharma.Inds.: 1,518.40  [16.10]Tata Motors: 1,027.95  [20.10]Tata Steel: 167.35  [2.40]TCS: 3,863.75  [41.15]Tech Mahindra: 1,266.90  [4.95]Titan Company: 3,569.50  [19.65]UltraTech Cem.: 9,981.25  [14.50]Wipro: 457.25  [5.05] BSE NSE
Products & Services    >   Company Profile   >   Directors Report
Valencia Nutrition Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:542910NSE Symbol:NAP/E :0
ISIN Demat:INE08RT01016Div & Yield %:0EPS :0
Book Value:15.1229953Market Cap (Rs.Cr):61.44Face Value :10

To,

The Members,

Your Directors take pleasure in presenting their Ninth Annual Report on the Business and Operations of the Company and the Accounts for the Financial Year ended 31st March, 2022.

1.FINANCIAL PERFORMANCE OF THE COMPANY:

The summary of standalone financial highlights for the financial year ended March 31, 2022 and the previous financial year ended March 31, 2021 is given below:

Amount fRs. In lakhsl

Particulars 2021-22 2020-21
Total revenue for the year 0.04 97.78
Profit before depreciation, exceptional Items & Taxes (58.98) (296.81)
Depreciation for the year 7.55 13.43
Profit before exceptional items (66.53) (310.24)
Exceptional items 0.36 (47.40)
Profit/(loss) before tax (66.17) (357.64)
Tax for the year (including deferred tax - net)
Net profit / (loss) (66.17) (357.64)

FINANCIAL PERFORMANCE:

The Members of the Company are hereby informed that the Company suffered heavy cash burn due to Lock Down and entire team was asked to leave on November 30, 2020.

Company suffered severe jolt from the Resignation of its Founder Promoter and MD on 31.01.2021.

Post that Mr. Manish Turakhia along with the Directors were left alone to rebuilt the operations or close down the company. Upon the wise counsel of the investors, new team was to be build & inculcated, the Beverage Industry Nuance (Production, Distribution, Marketing) had to be understood from grass root level, the Bottling Partners & Vendors needed to be taken in confidence. Almost entire year went to reconnect the scattered dots.

Accordingly, few Business Planning were mulled and implemented later -

1. Production to be carried out at multiple location so as to distribute final product in the radius of 300km of Plant location.

2. All variants have to be produced in day wise schedule.

3. Products to be supplied in Truck Load with all the variant in each truck straight to the Distributors (This practice does away with Central Warehouse, multiple Loading & Unloading and Damages/Shortages as Central Warehouse.)

4. We adopted policy of Only Sales without Sales Support.

5. Doing away with Sale or Return Policy. Products once SOLD to Distributors will be their property and they will have to sell to Retailers. (Only Manufacturing Defects will be replaced but unsold inventory will not be replaced.)

6. To do away large with Sales Force at Retail level to take orders. This has to be achieved via implementation of Valencia WebApp looping Super Stockist, Distributors & Retailer.

The total Income of the Company stood at Rs. 0.04 lakhs for the year ended March 31, 2022 as against Rs. 97.78 lakhs in the previous year. The Company incurred a Net loss for the year ended March 31, 2022 Rs. 66.17 lakhs as compared to the Net loss of Rs. 357.64 lakhs in the previous year.

1. DIVIDEND:

As the Company incurred a net loss during the year, your Directors do not propose any dividends for the Financial Year ending 31st of March, 2022.

2. TRANSFER TO RESERVE:

The Company has not transferred any amount to Reserves during the year.

3. UNPAID DIVIDEND & IEPF:

The Company was not required to transfer any amount to the Investor Education & Protection Fund (IEPF).

4.STATE OF AFFAIRS OF THE COMPANY:

Information on the operations and financial performance, among others for the period under review, is given in the Management Discussion and Analysis Report which is annexed to this Report and is in accordance with the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

5.DIRECTORS AND KEY MANAGERIAL PERSONNEL:

a)Composition & Constitution of Board of Directors:

The Board of Directors as on date of this Report comprises of following Directors:

Sr. Name No. DIN/ PAN Designation
1. Mr. Stavan Ajmera 08112696 Chairman, NonExecutive Director
2. Mr. Manish Turakhia 02265579 Non-Executive Director
3. Mr. Jay Shah* 09072405 Executive-Whole time Director
4. Mr. Eshanya Guppta4* 01727743 Non-Executive Independent Director
5. Mr. Jaimin Patwa 08613495 Non-Executive Independent Director
6. Ms. Prabhha Shankarran 07906258 Executive Director

*Mr. Jay Shah (DIN: 09072405) was appointed as Whole time Director effective from September 1, 2021.

**Mr. Eshanya Guppta has been appointed as an Independent Director effective from May 31, 2021.

During the year under review, Mr. Haresh Sanghvi (DIN: 00006301) resigned from the post of Non-Executive Director with effect from May 31, 2021.

a) Composition & Constitution of Key Managerial Personnel:

The Key Managerial Personnel as on the date of this Report comprises of following:

Sr. Name No. DIN/ PAN Designation
1. Mr. Himanshu Pareek* CRKPP5901N Company Secretary and Compliance Officer
2. Mr. Aditya Agarwal** APGPA7704N Company Secretary and Compliance Officer
3. Mr. Jay Shah*** BJPPS6293E Chief Financial Officer & Whole-Time Director

*Mr. Himanshu Pareek (PAN: CRKPP5901N) resigned as Company

Secretary and Compliance Officer of the Company effective from

May 31, 2022.

*** Mr. Aditya Agarwal (PAN:APGPA7704N) was appointed as Company Secretary and Compliance Officer of the Company effective from June 08, 2022.

***Mr. Jay Shah having (PAN: BJPPS6293E/DIN:09072405) was appointed as a Chief Financial Officer (CFO) effective from March 01, 2021 and Whole-Time Director effective from September 1, 2021.

i.Committees of Board of Directors

The Board as on the date of this Report has three Committees of Board of Directors consisting of the following members:

a. Audit Committee

-Mr. Jaimin Patwa-Chairman, Non-Executive Independent Director -Mr. Eshanya Gupta -Member, Non-Executive Independent Director -Mr. Jay Shah -Member, Whole time Director & CFO

b. Nomination and Remuneration Committee

-Mr. Jaimin Patwa-Chairman, Non-Executive Independent Director -Mr. Eshanya Gupta -Member, Non-Executive Independent Director -Mr. Stavan Ajmera -Member, Non-Executive Director

c. Stakeholder's Relationship Committee

-Mr. Jaimin Patwa-Chairman, Non-Executive Independent Director -Mr. Manish Turakhia -Member, Non-Executive Director -Mr. Stavan Ajmera -Member, Non-Executive Director

i.Independent Directors

Independent Directors have provided their confirmation, that they meet the criteria of independence as provided in sub- section (6) of Section 149 of the Companies Act, 2013. An Independent Director shall hold office for a term up to five consecutive years on the Board of a Company, but shall be eligible for re-appointment for the next five years on the passing of a special resolution by the Company.

As on date of this Report, Mr. Eshanya Guppta & Mr. Jaimin Patwa are the Independent Directors of the Company.

Familiarisation Programme for Independent Directors: The

Company has an orientationprogramme upon induction of new Directors as well as other initiatives to update Directors on a continuous basis. The details of familiarisation programme of independent directors are available on the Company's website at www.valencianutrition.com.

i. Retirement by Rotation of the Directors

In accordance with the provisions of the Companies Act, 2013 and the Articles of Association of the Company, Mr. Stavan Ajmera (DIN: 08112696), Non-Executive Director of the Company, retires by rotation and offers himself for re-appointment.

The brief profile of Mr. Stavan Ajmera, the nature of his expertise in specific functional areas, names of the companies in which he has held Directorships, his shareholding etc. are furnished in the "Annexure 1" to notice of the ensuing Annual General Meeting.

ii. Key Managerial Personnel

Mr. Aditya Agarwal has been appointed as a Company Secretary and Compliance Officer of the Company with effect from June 08, 2022 in place of Mr. Himanshu Pareek who resigned from the office of Company Secretary and Compliance Officer effective from May 31, 2022.

Mr. Jay Shah is the Chief Financial Officer and appointed as WholeTime Director effective from September 1, 2021.

7.MEETINGS:

During the year under review, the Board of your Company met eight (8) times. The details of Board Meeting held and participation of Directors thereat is enumerated as below:

Sr. No. Date of meeting Total No. of Directors on the Date of Meeting No. of Directors attended % of Attendance
1 24-05-2021 6 5 83.33
2 31-05-2021 7 6 83.33
3 05-07-2021 6 6 100.00
4 09-07-2021 6 6 100.00
5 01-09-2021 6 6 100.00
6 12-11-2021 6 6 100.00
7 03-12-2021 6 6 100.00
8 20-01-2022 6 6 100.00

The details of Board Meetings held from April 01, 2021 to March 31, 2022 and attendance of each Director thereat is as follows:

Sr. Name of the Board No. Member No. of Meetings entitled to attend No. of Meetings attended %0f Attendance
1. Mr. Haresh Sanghvi 2 0 0
2. Mr. Stavan Ajmera 8 8 100
3. Mr. Manish Turakhia 8 8 100
4. Mr. Jay Shah 8 8 100
5. Mr. Jaimin Patwa B 8 100
6. Ms. Prabhha Shankarran 8 8 100
7. Mr. Eshanya Guppta 7 7 100

8.AUDIT COMMITTEE:

During the year under review, the Audit Committee comprised of Mr. Jaimin Patwa, Mr. Manish Turakhia and Mr. Haresh Sanghvi and as on May 31, 2021 it was re-constituted as Mr. Turakhia and Mr. Sanghvi stepped down and Mr. Eshanya Guppta and Mr. Jay Shah were added as the members of the said Audit Committee. As on the date of this Report, Mr. Jaimin Patwa, Mr. Eshanya Guppta and Mr. Jay Shah are the members of the Committee.

The Audit Committee met Five (5) times during the financial year ended March 31, 2022.

Sr. Date of meeting No. Total No. of Directors on the Date of Meeting No. of Directors attended % of Attendance
1 24-05-2021 3 3 100
2 09-07-2021 3 3 100
3 01-09-2021 3 3 100
4 12-11-2021 3 3 100
5 20-01-2022 3 3 100

The details of Audit Committee Meetings held from April 01, 2021 to March 31, 2022 and attendance of each Director thereat is as follows:

Sr. Name of the Committee No. Member No. of Committee Meetings entitled to attend No, Of Meetings attended % of Attendance
1. Mr. Haresh Sanghvi* 1 1 100
2. Mr. Manish Turakhia* 1 1 100
3. Mr. Jalmin Patwa 5 \

S

100
4. Mr. Jay Shah 4 4 100
5. Mr. Eshanya Gupta 4 4 100

*Stepped down effective from May 31, 2022

The Committee is governed by a terms of reference, which is in line with the regulatory requirements mandated by the Companies Act, 2013. Some of the important functions performed by the Committee are:

1. Oversight of the Company's financial reporting process and the disclosure of its financial information to ensure that the financial statements are correct, sufficient and credible;

2. Recommendation for appointment, remuneration and terms of appointment of auditors of our Company;

3. Approval of payment to statutory auditors for any other services rendered by the statutory auditors;

4. Reviewing, with the management, the annual financial statements and auditor's report thereon before submission to our Board for approval, with particular reference to:

(a) Matters required to be included in the Director's Responsibility Statement, to be included in our Board's report in terms of clause (c) of sub-section 3 of section 134 of the Companies Act;

(a) Changes, if any, in accounting policies and practices and reasons for the same;

(b) Major accounting entries involving estimates based on the exercise of judgment by management;

(c) Significant adjustments made in the financial statements arising out of audit findings;

(d) Compliance with listing and other legal requirements relating to financial statements;

(e) Disclosure of any related party transactions; and

(f) Qualifications in the draft audit report.

5. Reviewing, with the management, the quarterly financial statements before submission to our Board for approval;

6. Reviewing, with the management, the statement of uses / application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilized for purposes other than those stated in the offer document / prospectus / notice and the report submitted by the monitoring agency monitoring the utilization of proceeds of a public or rights issue, and making appropriate recommendations to our Board to take up steps in this matter;

7. Reviewing and monitoring the auditor's independence and performance, and effectiveness of audit process;

8. Approval of any subsequent modification of transactions of our Company with related parties;

9. Scrutiny of inter-corporate loans and investments;

10. Valuation of undertakings or assets of our Company, wherever it is necessary;

11. Evaluation of internal financial controls and risk management systems;

12. Reviewing, with the management, performance of statutory and internal auditors, adequacy of the internal control systems

13. Reviewing the adequacy of internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit;

14. Discussion with internal auditors of any significant findings and follow up thereon;

15. Reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to our Board;

16. Discussion with statutory auditors before the audit commences, about the nature and scope of audit as well as post- audit discussion to ascertain any area of concern;

17. Looking into the reasons for substantial defaults in the payment to depositors, debenture holders, shareholders (in case of nonpayment of declared dividends) and creditors;

18. Reviewing the functioning of the Whistle Blower Mechanism;

19. Approval of appointment of CFO (i.e., the whole-time finance Director or any other person heading the finance function or discharging that function) after assessing the qualifications, experience and background, etc. of the candidate;

20. Carrying out any other function as is mentioned in the terms of reference of the Audit Committee.

21. Reviewing the utilization of loans and/ or advances from/investment by the holding company in the subsidiary exceeding rupees 100 crore or 10% of the asset size of the subsidiary, whichever is lower including existing loans / advances / investments existing as on the date of coming into force of this provision.]

22. To consider and comment on rationale, cost-benefits and impact of schemes involving merger, demerger, amalgamation etc., on the listed entity and its shareholders.

23. Carrying out any other function as may be mentioned in the terms of reference of the Audit Committee.

All the Members on the Audit Committee have the requisite qualification for appointment on the Committee and possess sound knowledge of finance, accounting practices and internal controls.

The Company Secretary acts as the Secretary to the Committee.

9.NOMINATION AND REMUNERATION COMMITTEE:

During the year under review, the Nomination and Remuneration Committee comprised of Mr. Jaimin Patwa, Mr. Manish Turakhia and Mr. Haresh Sanghvi and as on May 31, 2021 it was re-constituted as Mr. Turakhia and Mr. Sanghvi stepped down and Mr. Eshanya Guppta and Mr. Stavan Ajmera were added as the members of the said Committee. As on the date of this Report, Mr. Jaimin Patwa, Mr. Eshanya Guppta and Mr. Stavan Ajmera are the members of the Committee.

The Board has in accordance with the provisions of sub-section (3) of Section 178 of the Companies Act, 2013, formulated the policy setting out the criteria for determining qualifications, positive attributes, independence of a Director and policy relating to remuneration for Directors, Key Managerial Personnel and other employees.

During the year, the committee met two (2) times with full attendance of all the members with full attendance of all the members. The composition of the Nomination and Remuneration Committee as of March 31, 2022 and details of the Members participation at the Meetings of the Committee are as under:

S.N Date of meeting Total No. of Directors on the Date of Meeting No. of Directors attended %of Attendance
1 31-05-2021 3 3 100
2 01-09-2021 3 3 100

(The details of Nomination and Remuneration Committee Meetings held from April 01, 2021 to March 31, 2022 and attendance of each Director thereat is as follows:

Sr. Name of the Committee No. Member No. of Committee Meetings entitled to attend No. of Meetings attended % of Attendance
1 Mr. Haresh Sanghvi* 1 1 100
2 Mr. Manish Turakhia* 1 1 100
3 Mr. Jaimin Patwa 2 2 100
4. Mr. Eshanya Guppta 1 1 100
5. Mr. Stavan Ajmera 1 1 100

*Stepped down effective from May 31, 2022

The terms of reference of the Committee inter alia, include the following:

1. Formulation of the criteria for determining qualifications, positive attributes and independence of a Director and recommend to our Board a policy relating to the remuneration of the Directors, key managerial personnel and other employees;

2. Formulation of criteria for evaluation of independent Directors and our Board;

3. Devising a policy on Board diversity;

4. Identifying persons who are qualified to become Directors and who may be appointed in senior management in accordance with the criteria laid down, and recommend to our Board their appointment and removal;

5. Whether to extend or continue the term of appointment of the independent director, on the basis of the report of performance evaluation of independent directors.

6. Recommend to the board, all remuneration, in whatever form, payable to senior management.

^.STAKEHOLDERS' RELATIONSHIP COMMITTEE:

During the year under review, the Stakeholders' Relationship Committee, as per Section 178 (5) of Companies Act, 2013, is under Chairmanship of Mr. Jaimin Patwa, who was inducted in the Committee effective from May 31, 2022 and Mr. Stavan Ajmera and Mr. Manish Turakhia are the members of the said Committee. During the year, the committee met one (1) time with full attendance of all the members. The composition of the Stakeholders' Relationship Committee as at March 31, 2022 and details of the Members participation at the Meetings of the Committee are as under:

Sr. Date of meeting No. Total No. of Directors oil the Date of Meeting No, of Directors attended % of Attendance
1 20-01-2022 3 3 100

The details of Stakeholders' Relationship Committee Meetings held from April 01, 2021 to March 31, 2022 and attendance of each Director thereat is as follows:

Sr. Name of the Committee No. Member No. of Committee Meetings entitled to attend No. of Meetings attended % of Attendance
1. Mr. Jaimin Patwa 1 1 100
2. Mr. Stavan Ajmera 1 1 100
3. Mr. Manish Turakhia 1 1 100

The terms of reference of the Committee are:

1. Specifically look into various aspects of interest of shareholders, debenture holders and other security holders.

2. Resolving the grievances of the security holders of the listed entity including complaints related to transfer/transmission of shares, non-receipt of annual report, non-receipt of declared dividends, issue of new/duplicate certificates, general meetings etc.

3. Review of measures taken for effective exercise of voting rights by shareholders.

4. Review of adherence to the service standards adopted by the listed entity in respect of various services being rendered by the Registrar & Share T ransfer Agent.

5. Review of the various measures and initiatives taken by the listed entity for reducing the quantum of unclaimed dividends and ensuring timely receipt of dividend warrants/annual reports/statutory notices by the shareholders of the company

During the year, there were no complaints received from shareholder on SCORES. There are no balance complaints. The Company had no share transfers pending as on March 31, 2022.

11. BOARD EVALUATION:

Your Board has devised an Evaluation Policy for evaluating the performance of the Board, its Committees, Executive and NonExecutive Directors, Independent Directors. Based on the same, the performance was evaluated for the financial year ended March 31, 2022. As part of the evaluation process, the performance of NonIndependent Directors, the Chairman and the Board was conducted by the Independent Directors. The performance evaluation of the respective Committees and that of Independent and Non- Independent Directors was done by the Board excluding the Director being evaluated.

The policy inter alia provides the criteria for performance evaluation such as Board effectiveness, quality of discussion, contribution at the meetings, business acumen, strategic thinking, time commitment, and relationship with the stakeholders, corporate governance practices, contribution of the committees to the Board in discharging its functions etc.

The Board carried out formal annual evaluation of its own performance and that of its Committees viz., the Audit Committee, Stakeholders' Relationship Committee, Nomination and Remuneration Committee (NRC). The Board also carried out the performance evaluation of all the individual Directors including the Chairman of the Company. Additionally, NRC also carried out the evaluation of the performance of all the individual Directors and Chairman of the Company. The performance evaluation was carried out by way of obtaining feedback from the Directors through a structured questionnaire prepared in accordance with the policy adopted by the Board and after taking into consideration the Guidance Note on Board Evaluation issued by Securities and Exchange Board of India.

The feedback received from the Directors through the above questionnaire was reviewed by the Chairman of the Board and the Chairman of the NRC and then discussed the same at the meetings of the Board and NRC respectively. The performance evaluation of the Chairman, Wholetime Director and the Board as a whole was carried out by the Independent Directors at their separate meeting.

12. WEBLINK OF ANNUAL RETURN:

Pursuant to Section 134(3)(a) of the Companies Act, 2013, the Annual Return of the Company for the financial year ending on March 31, 2022 is available on the Company's website https://www.valencianutrition.com.

13. REMUNERATION POLICY:

The remuneration of the Board members is based on the Company's size, its economic and financial position, industrial trends and compensation paid by peer companies. The compensation reflects each Board member's responsibility and performance.

The Company has framed a Nomination and Remuneration Policy pursuant to Section 178 of the Companies Act, 2013 and SEBI (LODR) Regulations, 2015 which is available on the Company's website https://www.valencianutrition.com.

14. AUDITORS:

i. Statutory Auditors:

The Members of the Company at their Eighth Annual General Meeting held on September 28, 2021, had appointed M/s. Shah & Modi, Chartered Accountants (FRN: 112426W), as Statutory Auditors of the Company for a period of five years till the conclusion of thirteenth Annual General Meeting of the Company, in place of M/s. Manian and Rao, Chartered Accountants (FRN: 001983S) who resigned effective from September 1, 2021.

The comments, if any, on financial statements referred to in the Auditors' Report are self explanatory and do not call for any further explanations.

The Auditors' Report does not contain any qualification, reservation or adverse remark. No instances of fraud have been reported by the Statutory Auditors of the Company under Section 143(12) of the Companies Act, 2013.

ii. Secretarial Auditor:

Pursuant to the provisions of Section 204 of the Companies Act, 2013 and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Company has appointed

M/s. Krupa Joisar & Associates, represented by its Proprietor Ms. Krupa Joisar, a firm of Company Secretaries in Practice (CP No. 15263), to undertake the Secretarial Audit of the Company for the F.Y. 2021-22. The Secretarial Audit Report for F.Y. 2021-22 is annexed herewith as "Annexure I" to the Board's Report.

Explanation to the qualifications made by Auditors in their report is explained as under:

(a) The Company failed to approve its annual audited financial results within prescribed timeline under Regulation 33 of SEBI (Lising Obligations and Disclosure Requirement) Regulations, and accordingly a penalty of Rs. 53,100/- The said non-compliance was inadvertent in nature and the said penalty was paid and was acknowledged the same in time.

(b) The Company sold its land parcel without prior approval of the Members of the Company under Section 180(1)(a) of the Companies Act, 2013 - The said Act was ratified by the Members.

(c) Mr. Jaimin Patwa was appointed as an Additional Director on May 11, 2020 and his appointment was not confirmed at the immediate annual general meeting; however the same was confirmed by the Members of the Company on September 28, 2021 - Inadvertently missed and the appointment was approved by the Members.

(d) The Audited Financial Results of the Company for year ended March 31, 2022 were approved, signed by the Board and disseminated on the BSE Website on May 30, 2022 as per Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015 and the Independent Auditor's Report alongwith the Annexures was signed on August 30, 2022 -

The Company has approved and signed the Audited Annual Results within 60 days from the end of the Financial Year which is in time and hence, has complied with the provisions of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015 and since there is no timeline mentioned in the Companies Act 2013, there is no violation of the Companies Act 2013.

iii. Internal Auditor:

Pursuant to the provisions of Section 138 of the Companies Act, 2013 and other applicable provisions if any, the Company has appointed M/s SPDS & Associates LLP on January 20, 2022, Chartered Accountants (FRN: W100383), to undertake the internal audit of the Company for financial year 2021-22.

iv. Cost Auditor:

Appointment of Cost Auditor is not applicable to the Company.

15. VIGIL MECHANISM:

In pursuance of the provisions of section 177(9) & (10) of the Companies Act, 2013, a Vigil Mechanism for Directors and Employees to report genuine concerns has been established. Affirmation is also given that no personnel has been denied access to the audit committee.

16. INTERNAL FINANCIAL CONTROLS:

The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. During the year under review, no material or serious observation has been observed.

17. RISK ASSESSMENT AND MANAGEMENT:

The Company has been on a continuous basis reviewing and streamlining its various operational and business risks involved in its business as part of its risk management policy. The Company also takes all efforts to train its employees from time to time to handle and minimize these risks.

18. DETAILS OF SUBSIDIARY/JOINT VENTURES / ASSOCIATE COMPANIES:

The Company does not have any Subsidiary, Joint venture or Associate companies.

19. COMPLIANCE WITH SECRETARIAL STANDARDS:

The Company is compliant with the applicable Secretarial Standards (SS) viz. SS-1 & SS-2 on Meetings of the Board of Directors and General Meetings, respectively.

20. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:

i. Conservation of Energy

a) The steps taken or impact on conservation of energy - The Operations of the Company are not energy intensive. However, adequate measures have been initiated for conservation of energy.

b) The steps taken by the Company for utilizing alternate source of energy - Company shall consider on adoption of alternate source of energy as and when necessities.

c) The Capital Investment on energy conversation equipment - No Capital Investment yet.

ii. Technology absorption

a) The efforts made towards technology absorption. - Minimum technology required for Business is absorbed.

b) The benefits derived like product improvement, cost reduction, product development or import substitution - Nil

c) In case of imported technology (imported during the last three years reckoned from the beginning of the financial year) - Not Applicable.

a. the details of technology imported;

b. the year of import;

c. whether the technology been fully absorbed;

d. if not fully absorbed, areas where absorption has not taken place, and the reasons thereof

iii. The expenditure incurred on Research and Development- Not Applicable.

iv. Foreign Exchange earnings and outgo: NIL

21. PARTICULARS OF LOANS, INVESTMENTS AND GUARANTEES:

There were no loans, guarantees provided during the year which is falling under section 186 of the Companies Act, 2013.

22. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:

All related party transactions during FY22 were in the ordinary course of business and at arm's length terms. During FY22, Audit Committee has reviewed on quarterly basis, the related party transactions of the Company against the omnibus approval accorded by Audit Committee.

During FY22, there were no material related party transactions including transaction involving payments made to related party with respect to brand usage/ royalty, requiring approval of the shareholders. Furthermore, there were no contracts/arrangements with related parties referred to in sub-section (1) of Section 188 of the Companies Act, 2013.

Related party transactions during FY22, were in compliance with the Companies Act, 2013, SEBI Listing Regulations and Accounting Standards and are disclosed in the notes forming part of the financial statements.

23. DEPOSITS:

Your Company did not accept / hold any deposits from public / shareholders during the year under review.

24. SIGNIFICANT AND MATERIAL ORDERS:

There are no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and Company's operations in future.

The Company has shifted its registered office from Bangalore, in the state of Karnataka to Mumbai, in the state of Maharashtra as majority of the new management belongs to Mumbai and this would save the administrative costs of the Company to have new business avenues. In this connection, the Company received order from Regional Director (RD), South-Eastern region to shift the registered office dated March 11, 2022.

25. OBLIGATION OF COMPANY UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

In accordance with the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and rules made there under, the Company has framed and adopted the policy for Prevention of Sexual Harassment at Workplace. Company was not in receipt of any complaint of sexual harassment during the year.

26. .PARTICULARS OF EMPLOYEES

The information pursuant to Section 197 of the Companies Act, 2013 read with Rule 5(2) of The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is not applicable, since during the year under review none of the employees of the Company was in receipt of remuneration in excess of the limits specified, whether employed for the whole year or part thereof.

27. CHANGES IN NATURE OF BUSINESS

There was no change in nature of Business during the year.

28. CORPORATE SOCIAL RESPONSIBILITY

The provisions of the Section 135 of the Companies Act, 2013 is not applicable to the Company.

29. HUMAN RESOURCES:

Your Company considers people as its biggest assets and 'Believing in People' is at the heart of its human resource strategy. It has put concerted efforts in talent management and succession planning practices, strong performance management and learning and training initiatives to ensure that your Company consistently develops inspiring, strong and credible leadership.

Your Company has established an organization structure that is agile and focused on delivering business results. With regular communication and sustained efforts it is ensuring that employees are aligned on common objectives and have the right information on business evolution. Your Company strongly believes in fostering a culture of trust and mutual respect in all its employees seek to ensure that business world values and principles are understood by all and are the reference point in all people matters.

The current workforce breakdown structure has a good mix of employees at all levels. Your Board confirms that the remuneration is as per the remuneration policy of the Company. As on March 31, 2022, the Company had only 3 employees.

30. DIRECTORS' RESPONSIBILITY STATEMENT:

Pursuant to Section 134(5) of the Companies Act, 2013, the board of Directors, to the best of their knowledge and ability, confirm that:

i.In the preparation of the annual accounts, the applicable accounting standards have been followed and there are no material departures.

ii.They have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit/loss of the Company for that period.

i. They have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

ii. They have prepared the annual accounts on a going concern basis.

iii. They have laid down internal financial controls to be followed by the Company and such internal financial controls are adequate and operating effectively.

iv. They have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

Based on the framework of internal financial controls and compliance systems established and maintained by the Company, work performed by the internal and statutory auditors and external consultants and the reviews performed by management and the relevant board committees, including the audit committee, the board is of the opinion that the Company's internal financial controls were adequate and effective during the financial year 202122.

31. DISCLOSURE UNDER SECTION 43(a)(ii) OF THE COMPANIES ACT, 2013:

The Company has not issued any shares with differential rights as to dividend, voting or otherwise and hence no information as per provisions of Section 43(a)(ii) of the Act read with Rule 4(4) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.

32. DISCLOSURE UNDER SECTION 54(1)(d) OF THE COMPANIES ACT, 2013:

The Company has not issued any sweat equity shares during the year under review and hence no information as per provisions of Section 54(1)(d) of the Act read with Rule 8(13) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.

33. DISCLOSURE UNDER SECTION 62(1)(b) OF THE COMPANIES ACT,2013:

The Company has not issued any equity shares under Employees Stock Option Scheme during the year under review and hence no information as per provisions of Section 62(1)(b) of the Act read with Rule 12(9) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.

34. DISCLOSURE UNDER SECTION 67(3) OF THE COMPANIES ACT, 2013:

During the year under review, there were no instances of nonexercising of voting rights in respect of shares purchased directly by employees under a scheme pursuant to Section 67(3) of the Act read with Rule 16(4) of Companies (Share Capital and Debentures) Rules, 2014 is furnished.

25. REPORTING OF FRAUD:

The Auditors of the Company have not reported any instances of fraud committed against the Company by its officers or employees as specified under Section 143(12) of the Companies Act, 2013.

36. CAUTIONARY STATEMENTS:

Statements in this Annual Report, particularly those which relate to Management Discussion and Analysis as explained in the Corporate Governance Report, describing the Company's objectives, projections, estimates and expectations may constitute 'forward looking statements' within the meaning of applicable laws and regulations. Actual results might differ materially from those either expressed or implied in the statement depending on the circumstances.

37. ACKNOWLEDGEMENTS:

Your Directors would like to express deep sense of appreciation for the assistance and co-operation received from the Financial Institutions, Banks, Government Authorities and Shareholders and for the devoted service by the Executives, staff and workers of the Company. The Directors express their gratitude towards each one of them.

38. RELATIONSHIPS BETWEEN DIRECTORS INTER_SE:

None of the Directors is related to each other and there are no inter se relationships between theDirectors.

39. SHAREHOLDING OF DIRECTORS AS ON MARCH 31, 2022:

As on March 31, 2022, no other Director (except as mentioned below) holds any shares in the Company. The Company has not issued any convertible instruments

Sr. Name of the No. Directors Shareholding at the beginning of the year Shareholding at the end of the year.
1. Mr. Manish Turakhia, NonExecutive Director 2,38,329 shares (4.27%) 2,38,329shares (4.27%)
2. Ms. Prabhha Shankarran, Executive Director 10,400 shares (0.19%) 10,400shares (0.19%)
3. Mr. Stavan Ajmera, Non Executive Director 2,600 shares (0.05%) 2,600 shares (0.05%)

40. BOARD-SKILLS/EXPERTISE/COMPETENCIES:

The Board of directors based on the recommendations of the Nomination and Remuneration Committee, identified the following core skills/expertise/competencies of Directors as required in the context of business of the Company for its effective functioning:

Sr. Skills/Expertise/Competencies No
1 Leadership qualities
2 Industry knowledge and experience
3 Understanding of relevant laws, rules and regulations
4 Financial Expertise
5 Risk Management

Following are the details of the skills and competence possessed by the Board of Directors:

S.N Name of Directors Leadership qualities Industry knowledge and experience Understanding of relevant laws, rules and regulations Financial Expertise Risk Management
1 Mr. Stavan Ajmera Expert Expert Expert Expert Expert
2 Mr. Manish Turakhia Proficient Expert Proficient Expert Proficient
3 Mr. Jay Shah Expert Expert Proficient Expert Proficient
4 Mr. Eshanya Guppta Expert Expert Expert Expert Expert
5 Mr. Jaimin Patwa Expert Expert Expert Expert Expert
6 Ms. Prabhha Shankarran Expert Expert Expert Expert Expert

The identified skills / competences are broad-based and marking of 'Proficient' against a particular member does not necessarily mean the member does not possess the corresponding skills / competences.

41. DETAILS OF REMUNERATION TO ALL THE DIRECTORS AND KEY MANAGERIAL PERSONNEL:

Name of the Directors Salary, Allowance, perquisites and other benefits Performance- linked Income/Bonu s/Commission Paid/Payable Stock Option Pension Sitting Fees Paid
Executive Directors
Ms. Prabhha Shankarran Rs. 4,20,000/- Nil
Mr. Jay Shah Nil
Non-Executive Directors
Mr. Stavan Ajmera Nil
Mr. Manish Turakhia
Mr. Jaimin Patwa
Mr. Haresh Sanghvi*

* Mr. Haresh Sanghvi resigned from the Company with effect from May 31, 2021

REMUNERATION TO KEY MANAGERIAL PERSONNEL OTHER THAN MD / MANAGER/WTD DURING FY 2021-2022 *

S Particulars of N Remuneration Remuneration (in Rs.) till the date of employment
Name Himanshu Pareek Total
Designation Company Secretary and Compliance Officer
1 Gross salary
(a] Salary as per provisions contained in section 17(1) of the Income-tax Act, 1961 1,90,000 p.a. 1,90,000 p.a.
(b) Value of perquisites u/s 17(2) Income- tax Act, 1961 Nil Nil
(c) Profits in lieu of salary undersection
17(3) Income-tax Act, 1961
2 Stock Option
3 Sweat Equity
4 Commission
- as % of profit
- others, specify...
5 Others, please specify
Total 1,90,000 p.a. 1,90,000 p.a.

 

*Mr. Himanshu Pareek was appointed on May 24, 2021.

Disclosure of Managerial Remuneration

A. Ratio of remuneration of each Director to the median remuneration of the employees of the Company for FY 2021-22 as well as the percentage increase in remuneration of each Director, Chief Financial Officer and Company Secretary is as under:

Name of Director/ Key Managerial Personnel Ratio to median remuneration % increase in remuneration over previous year
Non-Executive Directors
Mr. Stavan Ajmera This is not applicable as the Company did not pay any remuneration to its directors.
Mr. Jaimin Patwa
Mr. Manish Turakhia
Mr. Haresh Sanghvl
Mr. Eshanya Guppta
Executive Directors
Mr. Jay Shah This is not applicable as the Company did not pay remuneration
Ms. Prabha Shankaran 1.84:1 Nil
Key Managerial Personnel
Mr. Jay Shah* This is not applicable as the Company did not pay remuneration
Mr. Himanshu Pareek** 1:1 This is not applicable as no increment was made in the FY 2021-22.
Mr. Aditya Agarwal*** 1:1

*Mr. Jay Shah has been appointed as whole-Time Director (with effect from September 1, 2021) of the Company.

**Mr. Himanshu Pareek resigned as Company Secretary and Compliance Officer of the Company effective from May 31, 2022. ***Mr. Aditya Agarwal has been appointed as a Company Secretary and Compliance Officer of the Company effective from June 08, 2022.

B. Percentage decrease in the median remuneration of employees in FY 2021-22: 36.48%

C. Number of permanent employees on the rolls of the Company as on March 31, 2022:3

D. Comparison of average percentile increase in salary of employees other than the managerial personnel and the percentile increase in the managerial remuneration:

Particulars % change in remuneration
Average decrease in salary of employees (other than managerial personnel) 15.79%
Average decrease in remuneration of managerial personnel 85.54%

Affirmation: It is affirmed that the remuneration paid to the Directors, Key Managerial Personnel and other employees is as per the Remuneration Policy of the Company.

PENALTIES / PUNISHMENT/ COMPOUNDING OF OFFENCES:

Type Section of the Companies Act Brief Description Details of Penalty / Punishment/ Compounding fees imposed Authority [RD/ NCLT/ COURT] Appeal made, if any (give Details)
A. COMPANY
Penalty NONE
Punishment
Compounding
B. DIRECTORS
Penalty NONE
Punishment
Compounding
C. OTHER OFFICERS IN DEFAU LT
Penalty NONE
Punishment
Compounding

The Company failed to approve its annual audited financial results within prescribed timeline under Regulation 33 of SEBI (Lising Obligations and Disclosure Requirement) Regulations, and accordingly a penalty of Rs. 53,100/- was to levied by BSE. The payment for the same was made by the Company within due time.

42. GENERAL SHAREHOLDER INFORMATIONS:

a) 9th Annual General Meeting

Date Time Venue
29^ September, 2022 12 Noon AGM will be held through electronic mode [video conference or other audiovisual means ("OAVM")]

b) Financial Calendar for the year 2021-2022

Financial year 1st April, 2021 to 31s* March, 2022
Book Closure Dates September 22,2022- September 29, 2022 (both days inclusive)

c) Listing of Equity Shares on Stock Exchange and Stock Codes Listing on Stock Exchange:

BSE Limited ("BSE")

Phiroze Jeejeebhoy Towers Dalal Street, Mumbai 400 023 SCRIP CODE: 542910

d) Location and time, where Annual General Meeting (AGM) for the last 3 years were held is given below:

Financial Year AGM Date Time Location
2020-21 Siti Tuesday, September 28,2021 11.00 a.m. Video-Conferencing/ Other Audio-Visual Means
2019-20 7th Wednesday, September 30,2020 11.00 a.m. 11, 7th Block. 33rd Main. Banagirinagar, Banashankari 3rd Stage, Bengaluru - 560 085
2018-19 6th Monday, 30 September. 2019 11.00 a.m. 11, 7th Block, 33rd Main, Banagirinagar, Banashankari 3rd Stage, Bengaluru - 560 085

e) Stock Market Date and their Performance v/s S&P BSE Sensex The high/low of the market price of the shares of the Company is as follows:

Month BSE (Rs.)
High Low
April-2021 17.10 16.40
May-2021 15.40 13.60
June-2021 17.50 13.70
July-2021 21.00 17.50
August-2021 18.70 17.50
September-2021 17.30 15.95
October-2021 16.20 16.20
November-2021 - -
December-2021 16.10 15.95
January-2022 16.10 15.95
February-2022 17.50 14.80
March-2022 16.10 12.75

f) Registrar and Share Transfer Agent (RTA)

REGISTRAR AND SHARE TRANSFER AGENT: Bigshare Services Private Limited 1st Floor, Bharat Tin Works Building,

Opp. Vasant Oasis, Makwana Road, Marol, Andheri East, Mumbai-400 059 Tel: 022 62638200.

Fax: 2851 2885

website: https://www.bigshareonline.com/

Share transfer system:

The Board has the authority for approving transfer, transmission of the Company's securities. The Company ensures that the half yearly Compliance Certificate pursuant to regulations 40(9) and 40 (10) of the SEBI Listing Regulations are filed with the Stock Exchanges.

As per SEBI Notification No. SEBI/LAD-NRO/GN/2018/24 dated June 8, 2018 and further amendment vide Notification No. SEBI/LAD- NRO/GN/2018/49 dated November 30, 2018, requests for effecting transfer of securities (except in case of transmission or transposition of securities) cannot be processed from April 1, 2019 unless the securities are held in the dematerialized form with the depositories.

The Board appreciates that all the members are holding shares in dematerialized form.

Distribution of shareholding:

Nominal Value of Shares: Rs. 10

Category Shareholders Shares
(Shares) Number % Number %
501-1000 l 0.9524 900 0.0161
1001-2000 1 0.9524 1300 0.0233
2001-3000 48 45.7143 143600 2.5710
3001-4000 3 2.8571 11550 0.2068
5001-10000 17 16.1905 113200 2.0267
10001 - 9999999999 35 33.3333 5314791 95.1561
Total 105 100.0000 5585341 100.0000

g) Dematerialization of Shares :

The Company's shares are required to be compulsorily traded on Stock Exchanges in dematerialized form. The number of shares as on 31st March, 2022 held in dematerialized and physical form are as under.

Particulars No. of Shares %
NSDL 25,01,114 44.78
CDSL 30,84,227 55.22
Physical 0 0
Total 55,85,341 100

h) Compliance with mandatory and non-mandatory requirements of the Listing Regulations:

The Company has complied with all mandatory requirements of Listing Regulations and has not adopted any non-mandatory requirements which are not applicable to the Company.

43. Corporate Governance

The Company does not fall under purview of Regulations of Corporate Governance.

Pursuant to Regulation 15 of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015, the provisions of reporting of Corporate Governance as specified in Regulation 27 (2) is not applicable to the Company, as it is SME Listed Company.

Though the Corporate Governance is not applicable to the Company, the Company has given certain disclosures as a practice of good corporate governance.

Registered Office:

SH-4, A Wing, Bldg. No. 34, Tilak Nagar Chembur Sahvas Cooperative HSG Soc, Mumbai - 400089 Tel : 080 - 26799552 CIN: L51909MH2013PLC381314 Website: http://www.valencianutrition.com Email:info@valendanutrition.com

By Order of the Board of Directors For VALENCIA NUTRITION LIMITED

Sd/- Sd/-
Stavan Ajmera Jay Shah
DIN: 08112696 DIN:09072405
The Chairman Whole Time Director & CFO
Date: August 30, 2022
Place: Mumbai

   

             SEBI Common Reg. No. INZ000206338          MCX MEMBERSHIP ID:12535 MAPIN NO:10014845        CDSL : IN-DP-CDSL-291-2005
MERCHANT BANKING REGISTRATION NO : NM000011575
Terms of the Site   I   Privacy Policy   I  Disclaimer   I  Broker Norms   I   Investor Complaint   I  Investor Relations   I  Investor Charter   I  Site Map   I  Payment Gateway   I  Circular   I  Upfront Margin   I  Pricing   I  Investor Complaints   I  Depository Participant   I  Investor Complaints for DP   I  CDSL E-Voting  I  Maintenance of Website  I   Details of authorized persons  I   SMART ODR  I  
INTERNAL CONTROL POLICY  I  AML POLICY  I  RMS POLICY  I  POLICIES & PROCEDURES  I  CLIENT ACCEPTANCE POLICY   I  CLIENT REGISTRATION FORM  I  DOCUMENTS IN VERNACULAR LANGUAGES
BSE  I  NSE  I  CDSL  I  SEBI  I  MCX  I  NCDEX
© 2010 SHARE MART. All rights reserved Designed, Developed and Content provided by CMOTS Infotech ( ISO 9001:2015 certified )